Table 4. Multivariate analysis comparing patients currently aged under 40years with early onset psoriasis and patients with late onset psoriasis.
| P-value | OR (95%CI) | |
|---|---|---|
| NAFLD | ||
| Sex | 0.002 | 3.880 (1.862–8.082) |
| Age at onset, (EOP vs LOP)a | 0.000 | 0.098 (0.051–0.190) |
| Metabolic syndrome | 0.000 | 0.124 (0.048–0.324) |
| Disease duration | NS | |
| Hypertriglyceridemia | ||
| Sex | 0.077 | |
| Age at onset (EOP vs LOP)a | 0.001 | 0.422(0.249–0.716) |
| Disease duration | 0.065 | |
| Diabetes | ||
| Sex | 0.142 | |
| Age at onset (EOP vs LOP)a | 0.000 | 5.406 (2.539–11.511) |
| Disease duration | NS | |
| Metabolic syndrome | ||
| Sex | NS | |
| Age at onset (EOP vs LOP)a | NS | |
| Disease duration | NS | |
| Hyperuricemia | ||
| Sex | NS | |
| Age at onset (EOP vs LOP)a | 0.000 | 0.106 (0.038–0.295) |
| Metabolic syndrome | 0.021 | 0.324(0.124–0.846) |
| Disease duration | NS |
OR, odds ratio; CI, confidence interval. NAFLD, nonalcoholic fatty liver disease.
a: early onset psoriasis (EOP), late-onset psoriasis (LOP). NS, not significant